🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 6 of 78

  1. US 11814440

    Glypican 2 as a cancer marker and therapeutic target

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11806389

    Compositions and methods for treating central nervous system injury

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11806369

    Exosomes and miRNA to treat glaucoma

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11807682

    M971 chimeric antigen receptors

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11806406

    Virus-like particle conjugates for diagnosis and treatment of tumors

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11801241

    Muscarinic M2 receptor blockade to delay or prevent onset of progressive memory decline

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11802283

    Oligonucleotide analogues targeting human LMNA

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11801265

    Preparation method of NK cells and use thereof in the treatment of cancer

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11801296

    Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11793870

    Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11793871

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11793772

    Pharmaceutical composition comprising THA as active ingredient for treating breast cancer

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11793780

    Prodrugs of treprosiinil

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11795235

    Immunotoxins with albumin binding domain

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11793860

    Vault complexes for cytokine delivery

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11787764

    Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11786601

    Pegylated capsule-degrading enzyme for the treatment of anthrax

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11787840

    Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11786591

    Recombinant metapneumovirus F proteins and their use

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11786540

    Gliflozins and a method for their delivery during resuscitation from cardiac arrest to improve survival outcomes

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11786589

    Human rotavirus strains and vaccines

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11779601

    Diagnostic methods for T cell therapy

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11779603

    HERV-E reactive T cell receptors and methods of use

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11780885

    Zika viral antigen constructs

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11782065

    Kits and methods for prediction and treatment of preeclampsia

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11779570

    Method for inhibiting dengue virus infection

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11781955

    Photo-controlled removal of targets in vitro and in vivo

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11780931

    CD47 targeted therapies for the treatment of infectious disease

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11771737

    Treating or preventing adverse liver conditions

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11773148

    Tau peptide immunogen constructs

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11771739

    Methods and compositions for treating microbial inflammation

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11766403

    Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11766476

    Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11760789

    Broadly neutralizing antibodies against HIV

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11760790

    Neutralizing antibodies to HIV-1 Env and their use

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11760794

    Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11759513

    Human rotavirus G9P[6] strain and use as a vaccine

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11752138

    Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11753377

    Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11753408

    Compounds and method for blocking transmission of malarial parasite

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11753627

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11752220

    Method of delivering genes and drugs to a posterior segment of an eye

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11746335

    Development of dengue virus vaccine components

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11744831

    Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11744834

    Metal-porphyrin complexes for the inactivation of the biological activity of opioids

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11739063

    DREADD actuators

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11739137

    Single domain antibodies to SARS-CoV-2 nucleocapsid protein

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.